The Guide provides the latest legal information on the regulatory framework for Life Sciences; clinical trials; the marketing, manufacturing and distribution of pharmaceuticals and medical devices; their import, export and pricing; and regulatory reliance.
In this latest edition, Patrícia Paias, Francisco Marques de Azevedo and Clara Nolasco Lamas comment on how Portugal’s pharmaceutical and Life Sciences sector is changing in 2025–2026, especially under the influence of new EU-wide regulations and national policy reform.